Biochemical effects of desferrioxamine in hepatic cells of Swiss albino mice
Pakistan Journal of Pharmacology. 1992; 9 (1): 84-8
em Inglês
| IMEMR
| ID: emr-26001
ABSTRACT
Desferrioxamine [DFO] used as a chelator in treatment of chronic iron over load diseases was evaluated for its effects on proteins and nucleic acid contents in hepatic cells of mice on acute and sub - acute treatment. The acute treatment of DFO failed to significantly affect the levels of proteins and nucleic acids in hepatic cells. However, on sub - acute administration for 7 days, DFO was found to reduce the levels of RNA and DNA compared to control. These changes were statistically insignificant; however the results clearly indicated the weak cytotoxic potentials of DFO on sub - acute treatment
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Quelantes de Ferro
/
Desferroxamina
/
Camundongos
Idioma:
Inglês
Revista:
Pak. J. Pharmacol.
Ano de publicação:
1992
Similares
MEDLINE
...
LILACS
LIS